Smith & Nephew PLC
LSE:SN
Smith & Nephew PLC
LSE:SN
Price:
996.8 GBX
1.14%
Market Closed
Updated:
May 6, 2024
Smith & Nephew PLC
Operating Income
|
Smith & Nephew PLC
Operating Income Peer Comparison
Comparables:
LIVN
LMDX
EKF
AGL
CREO
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Smith & Nephew PLC
LSE:SN
|
Operating Income
$763m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Operating Income
$57m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Operating Income
-$225.1m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Operating Income
£4.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
7%
|
|
|
Angle PLC
LSE:AGL
|
Operating Income
-£24.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Operating Income
-£30.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Smith & Nephew PLC's Operating Income?
Operating Income
763m
USD
763m
USD
Based on the financial report for Dec 31, 2023, Smith & Nephew PLC's Operating Income amounts to 763m USD.
What is Smith & Nephew PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-5%
-5%
Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Smith & Nephew PLC have been 14% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
